tradingkey.logo
tradingkey.logo
Search

Bright Minds Biosciences Inc

DRUG
Add to Watchlist
73.260USD
-1.370-1.84%
Close 07-31 16:00ETQuotes delayed by 15 min
721.85MMarket Cap
LossP/E TTM

DRUG Financials

See Bright Minds Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Bright Minds Biosciences Inc Earnings Date

Latest Release
May 20, 2026
EPS / Forecast
-0.78/-0.86
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.28
-165.73%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-169.04%-0.78
-12787.48%-0.71
-233.90%-0.43
-1544.52%-0.54
-206.65%-0.29
101.69%0.01
57.16%-0.13
102.58%0.04
76.28%-0.10
31.13%-0.33
---0.30
---1.46
---0.40
---0.48
----
----
----
----
----
----
Net Profit
-259.96%-7.61M
-16004.08%-5.56M
-453.98%-2.99M
-2363.68%-3.79M
-400.84%-2.11M
102.79%34.96K
53.29%-538.87K
115.47%167.64K
72.28%-422.13K
28.15%-1.25M
47.22%-1.15M
47.94%-1.08M
56.42%-1.52M
54.33%-1.74M
2.50%-2.19M
25.78%-2.08M
-166.20%-3.49M
-623.53%-3.82M
-689.08%-2.24M
-6971.50%-2.80M
Debt to assets ratio
-91.09%0.03%
-63.11%0.12%
-92.35%0.15%
20.33%0.27%
-44.52%0.30%
-60.50%0.31%
82.26%1.95%
-79.34%0.22%
-50.97%0.53%
-26.49%0.79%
--1.07%
--1.08%
--1.08%
--1.08%
----
----
----
----
----
----
Operating profit
-365.75%-11.14M
-344.54%-5.07M
-652.24%-4.13M
-1482.95%-2.38M
-485.29%-2.39M
9.58%-1.14M
54.00%-549.50K
116.04%172.07K
73.13%-408.75K
26.29%-1.26M
46.22%-1.19M
48.55%-1.07M
56.36%-1.52M
54.86%-1.71M
4.25%-2.22M
27.98%-2.08M
-170.19%-3.49M
-655.40%-3.79M
---2.32M
---2.89M
Net Profit
-259.96%-7.61M
-16004.08%-5.56M
-453.98%-2.99M
-2363.68%-3.79M
-400.84%-2.11M
102.79%34.96K
53.29%-538.87K
115.47%167.64K
72.28%-422.13K
28.15%-1.25M
47.22%-1.15M
47.94%-1.08M
56.42%-1.52M
54.33%-1.74M
2.50%-2.19M
25.78%-2.08M
-166.20%-3.49M
-623.53%-3.82M
-689.08%-2.24M
-6971.50%-2.80M
Current assets
463.06%227.22M
62.63%66.72M
1376.85%61.60M
729.61%37.90M
744.28%40.35M
706.77%41.03M
-18.90%4.17M
-26.58%4.57M
-34.89%4.78M
-40.39%5.09M
-41.69%5.14M
-9.85%6.22M
-19.84%7.34M
-29.55%8.53M
-43.71%8.82M
-60.84%6.90M
-57.08%9.16M
598.47%12.11M
--15.67M
--17.63M
Total current liabilities
435.42%2.79M
257.62%1.16M
363.26%1.71M
236.19%437.89K
-16.25%520.83K
-48.80%325.22K
73.71%368.34K
-75.68%130.25K
-16.75%621.86K
61.14%635.16K
-80.49%212.05K
77.53%535.55K
-4.40%746.96K
2.47%394.16K
117.69%1.09M
17.74%301.67K
130.30%781.37K
243.57%384.66K
--499.35K
--256.22K
Total assets
461.65%227.27M
62.30%66.79M
1350.31%61.68M
730.06%38.00M
742.68%40.47M
703.55%41.15M
-18.11%4.25M
-27.18%4.58M
-35.26%4.80M
-40.59%5.12M
-41.79%5.19M
-8.96%6.29M
-19.02%7.42M
-28.81%8.62M
-43.06%8.92M
-60.83%6.90M
-57.08%9.16M
597.93%12.11M
--15.67M
--17.63M
Total liabilities
435.42%2.79M
191.81%1.18M
338.61%1.74M
271.11%483.38K
-16.25%520.83K
-36.59%402.78K
86.71%395.92K
-76.14%130.25K
-19.53%621.86K
46.05%635.16K
-81.40%212.05K
80.98%545.96K
-1.10%772.76K
13.06%434.89K
128.33%1.14M
17.74%301.67K
130.30%781.37K
243.57%384.66K
--499.35K
--256.22K
Total equity
461.99%224.49M
61.02%65.61M
1454.16%59.95M
743.50%37.51M
855.58%39.94M
808.34%40.75M
-22.57%3.86M
-22.52%4.45M
-37.09%4.18M
-45.20%4.49M
-35.99%4.98M
-13.07%5.74M
-20.69%6.64M
-30.18%8.19M
-48.70%7.78M
-61.99%6.60M
-60.11%8.38M
622.37%11.72M
--15.17M
--17.37M
Net operating income
-177.39%-6.73M
-186.02%-4.27M
-100.03%-926.50K
-1156.02%-2.54M
-201.24%-2.43M
-81.78%-1.49M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
43.74%-1.20M
42.33%-1.65M
58.51%-1.51M
46.20%-2.66M
10.92%-2.13M
3.72%-2.86M
-159.01%-3.65M
-800.97%-4.95M
---2.39M
---2.97M
Net investment
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
----
Net financing
73654.52%166.23M
-81.09%9.84M
103443.55%24.34M
44.39%-12.21K
1126.47%225.38K
5826.92%52.04M
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
-61.05%878.04K
-100.43%-21.64K
-279.07%-21.49K
-1376.13%-21.49K
1806.39%2.25M
52308.82%5.06M
102.20%12.00K
-99.99%1.68K
-93.76%118.25K
---9.70K
---545.55K

FAQs

What are the current assets of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its current assets were 61.60M, with a year-on-year change of 1376.85.

What are the total assets of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its total assets of Bright Minds Biosciences Inc were 61.68M, with a year-on-year change of 1350.31.

What are the total liabilities of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its total liabilities of Bright Minds Biosciences Inc were 1.74M, with a year-on-year change of 338.61.

What is the total equity of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its total equity of Bright Minds Biosciences Inc was 59.95M, with a year-on-year change of 1454.16.

What is the net operating income of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its net operating income of Bright Minds Biosciences Inc was -10.16M, with a year-on-year change of -418.13.

What is the net financing of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its net financing of Bright Minds Biosciences Inc was 62.52M, with a year-on-year change of 10970.91.

What is the Earnings Per Share (EPS) of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.28, with a year-on-year change of -165.73.

What is the net income of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its net income was -8.94M, with a year-on-year change of -357.73.

What is the debt-to-asset ratio of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its debt-to-asset ratio was 0.15, with a year-on-year change of -92.35.

What is the Return on Equity (ROE) of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -27.93, with a year-on-year change of 39.53.

What is the Return on Assets (ROA) of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -27.02, with a year-on-year change of 37.40.

What is the operating profit of Bright Minds Biosciences Inc?

According to Bright Minds Biosciences Inc's FY2025 earnings report, its operating profit was -10.16M, with a year-on-year change of -418.13.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.